| Not Yet Recruiting | Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center NCT07413146 | Sun Yat-sen University | N/A |
| Recruiting | Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC NCT07080944 | European Institute of Oncology | N/A |
| Recruiting | Megestrol Acetate in Improving Neoadjuvant Chemotherapy-Related Weight Loss in Locally Advanced CRC NCT06998758 | Sixth Affiliated Hospital, Sun Yat-sen University | Phase 3 |
| Not Yet Recruiting | Evaluation of Seismocardiography(SCG) for Assessing Fitness and Predicting Outcomes in Oesophageal Cancer Surg NCT07159711 | Guy's and St Thomas' NHS Foundation Trust | — |
| Not Yet Recruiting | Evaluating Bemotuzumab to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer ( NCT06975644 | Zhejiang Provincial People's Hospital | N/A |
| Not Yet Recruiting | Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients NCT07142863 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Phase 2 |
| Recruiting | The Better, Harder, Faster, Stronger Study NCT07220512 | Wake Forest University Health Sciences | — |
| Not Yet Recruiting | Fasting-Mimicking Diet as an Adjunct to Neoadjuvant Chemotherapy for Hormone-Receptor-Positive Breast Cancer NCT07077018 | Guangdong Provincial People's Hospital | N/A |
| Recruiting | Comparative Study Between Immediate Surgery Versus Neoadjuvant Chemotherapy for Management of Resectable Pancr NCT06978322 | Minia University | — |
| Completed | The Effect of Neoadjuvant Chemotherapy on Physical Functions NCT06986005 | ATİYE KAŞ ÖZDEMİR | — |
| Not Yet Recruiting | Efficacy and Safety of Neoadjuvant Sintilimab Plus FLOT Versus Sintilimab Plus SOX Phase II Clinical Trial for NCT06459921 | Xijing Hospital | Phase 2 |
| Unknown | Effect of Neoadjuvant Chemotherapy on Cardiac Function of Perioperative Patients With Breast Cancer and New St NCT06497660 | Fujian Medical University Union Hospital | Phase 4 |
| Recruiting | Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer NCT06220214 | Alison Stopeck | EARLY_Phase 1 |
| Not Yet Recruiting | Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab NCT06172036 | Zhejiang University | Phase 2 |
| Recruiting | Bladder Cancer Staging and Prediction of New Adjuvant Chemotherapy Efficacy Based on Deep Learning and Transfe NCT07051083 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | — |
| Recruiting | Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery NCT06281210 | European Institute of Oncology | N/A |
| Recruiting | Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer NCT06155305 | Second Affiliated Hospital, School of Medicine, Zhejiang University | — |
| Completed | Appraisal of the Modified Cancer Cachexia Index in Locally Advanced Gastric Cancer Patients Undergoing Neoadju NCT06689462 | Fujian Medical University | — |
| Unknown | New Prognostic Index for Neoadjuvant Chemotherapy Outcome in Patients With Advanced High-grade Serous Ovarian NCT06120309 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | — |
| Recruiting | Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC NCT06714604 | Sahlgrenska University Hospital | Phase 3 |
| Recruiting | Neoadjuvant Chemotherapy Combined With PD-1 + Radical Radiotherapy in Locally Advanced Cervical Cancer NCT05554276 | Shanghai Jiao Tong University Affiliated Sixth People's Hospital | Phase 2 |
| Recruiting | NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer) NCT05529940 | Seoul National University Hospital | Phase 3 |
| Unknown | Effect of Probiotic Supplements on Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy NCT05901779 | The Affiliated Hospital of Qingdao University | N/A |
| Suspended | Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer NCT05503108 | Leiden University Medical Center | Phase 3 |
| Unknown | Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer NCT05910710 | Samsung Medical Center | — |
| Completed | Muscle Parameters and Pathological Response in Breast Cancer Patients NCT06151379 | Acıbadem Atunizade Hospital | — |
| Unknown | DLCS for Predicting Neoadjuvant Chemotherapy Response NCT05617469 | Zhejiang Cancer Hospital | — |
| Recruiting | Neoadjuvant Chemotherapy Followed by Chemoradiation Versus Chemoradiation for Stage IIIC Cervical Cancer Patie NCT05367206 | Sun Yat-sen University | Phase 3 |
| Recruiting | Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic C NCT05202314 | Beijing Chao Yang Hospital | N/A |
| Completed | Prehabilitation During the Neoadjuvant Window of Opportunity in Older Women With Ovarian Cancer NCT05092763 | Northwestern University | N/A |
| Active Not Recruiting | Neoadjuvant Chemotherapytreatment of Locally Advanced Head and Neck Squamous Cell Carcinoma NCT05522985 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Not Yet Recruiting | Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer NCT04384601 | Ruijin Hospital | Phase 3 |
| Active Not Recruiting | Comparison of the Pathological Effect Between 2 and 4 Cycles Neoadjuvant CAPOX for Low/Intermediate Risk II/II NCT04922853 | West China Hospital | Phase 3 |
| Unknown | Paclitaxel i.v. Plus Cisplatin i.p for NACT in Patients With Advanced Ovarian Cancer NCT04885270 | West China Second University Hospital | Phase 3 |
| Unknown | FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal Cancer NCT05018182 | West China Hospital | Phase 2 |
| Unknown | Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervi NCT05189028 | Chuangzhen Chen | Phase 3 |
| Unknown | CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or NCT04913896 | The First Hospital of Jilin University | — |
| Unknown | PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer NCT04815408 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 2 |
| Unknown | Pembrolizumab Plus Neoadjuvant Chemotherapy for Locally Advanced EGJ Adenocarcinoma NCT04813523 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Unknown | Efficacy of Neoadjuvant Hyperthermic Intraperitoneal Chemotherapy in Advanced High-grade Serous Ovarian Cancer NCT05246020 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 2 |
| Recruiting | Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast NCT04576143 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 2 / Phase 3 |
| Unknown | Comparison of pCR Rate After Neadjuvant Chemotherapy Guided by Result of in Vitro Cell Culture Drug Sensitivit NCT04130750 | Peking University People's Hospital | EARLY_Phase 1 |
| Unknown | A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasophary NCT04061278 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 3 |
| Unknown | NAC Followed by RH for the Treatment of LACC NCT03963882 | Lei Li | Phase 2 |
| Unknown | MRI Radiomics Assessing Neoadjuvant Chemotherapy in Breast Cancer to Predict Lymph Node Metastasis and Prognos NCT04004559 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | — |
| Unknown | Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma NCT04047693 | Pusan National University Yangsan Hospital | Phase 2 |
| Active Not Recruiting | ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBC NCT04172259 | Sun Yat-sen University | Phase 2 |
| Completed | Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer NCT03750669 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 3 |
| Unknown | To Accurately Assess Lymph Node Response to NACT by Wire Localization of Clip-marked Lymph Nodes NCT03715686 | Peking University | N/A |
| Completed | Sentinel Lymph Node Biopsy After Neoadjuvant Treatment in Breast Cancer Patents NCT03719833 | Clinical Hospital Center Rijeka | — |
| Unknown | Potential of Circulating Tumor DNA to Assess the Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer P NCT03688035 | Zhiyong Yu | — |
| Unknown | Radiomics of Mp-MRI Assessing NAC Outcome in Breast Cancer NCT03592004 | Chinese Academy of Sciences | — |
| Unknown | Comparison of Ability of pCLE and WLE for Diagnosis and Cancer Tissue Acquisition in Advanced Gastric Cancer A NCT03449966 | Yonsei University | N/A |
| Unknown | Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Che NCT03349177 | Zhiyong Yu | Phase 2 / Phase 3 |
| Terminated | Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer NCT03585062 | Zhejiang Provincial People's Hospital | Phase 2 |
| Completed | Melatonin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response in Locally Advanced Oral Sq NCT04137627 | Indonesia University | Phase 3 |
| Unknown | Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer NCT02972541 | Beijing Chao Yang Hospital | N/A |
| Unknown | The Analysis of Immuno-Nutrition Index in Advanced Gastric Cancer Receiving Preoperative Treatments NCT03493880 | Peking University | — |
| Completed | DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer NCT02126449 | Leiden University Medical Center | Phase 2 / Phase 3 |
| Unknown | Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer NCT02041338 | Chinese Academy of Medical Sciences | Phase 2 |
| Unknown | Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherap NCT01652560 | LiNanlin,Ph.D, Chief Physician,Clinical Professor | — |
| Active Not Recruiting | Multimodal Therapy Impact on Pancreatic Cancer Survival NCT06938906 | National Cheng Kung University | — |
| Completed | Micrometastases in Axillary Lymph Nodes in Breast Cancer, Post-neoadjuvant Chemotherapy NCT06149884 | Gangnam Severance Hospital | — |